entertainment -WSS

entertainment

author：entertainment 2025-09-30 02:09:11 - browse：1

The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

“They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： HHS leader on health, climate change and biopharma emissions

WSS

UnitedHealth’s board chair also owns a personal investment firm

Eli Lilly expects to double planned employment in Boston center

Pharmacists can make shortage drugs, but at what cost?

Naloxone nonprofit donates 200,000 doses after FDA approval

Man killed during FBI raid in connection with threats against Biden, other officials

NIH confirmation hearing shows politicization of research

focus

entertainment

knowledge

At least 13 dead in Texas as scorching temps continue

Naloxone nonprofit donates 200,000 doses after FDA approval

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Sports medicine is finally prioritizing gender equality

How to use technology to prevent future drug shortages

DIEP, the 'gold standard' of breast reconstruction, is under threat

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

At least 13 dead in Texas as scorching temps continue

Why health workers in Gaza are injured or die at high rates

Wikipedia

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

The EU Joint Clinical Assessment needs to live up to its promise

How to use technology to prevent future drug shortages

Police still searching for prisoner who escaped from NYC hospital

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Researchers explore possible ties between long Covid, menopause

hotspot

focus

leisure time

hotspot